ArticleJACC. Case reports2025
Post-Transplant Lymphoproliferative Disorder Presenting as Biventricular Failure After Heart Transplantation.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe diagnosis of post-transplant lymphoproliferative disorder (PTLD) is challenging because of its diverse clinical presentations. CASE SUMMARY: A 65-year-old man, previously stable 61 months after heart transplantation for dilated cardiomyopathy, presented with biventricular failure and worsening dyspnea. Given the acute decline in graft function, acute rejection was suspected, and rejection therapy was initiated. However, the patient showed no clinical improvement, and he required venoarterial extracorporeal membrane oxygenation support as a bridge to redo heart transplantation. Pathologic evaluation of the explanted heart revealed a diagnosis of PTLD. DISCUSSION: This case underscores importance of recognizing PTLD as a potential cause of graft dysfunction in heart transplant recipients, particularly when rejection therapy is ineffective and biopsy findings are atypical. Further research is necessary to establish optimal treatment approaches. TAKE-HOME MESSAGES: PTLD can mimic acute rejection in heart transplant recipients, thus necessitating thorough histopathologic evaluation. Effective management, including tailored immunosuppressive strategy following retransplantation, needs further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.